RESUMEN
Background: The field of surgical and interventional thyroidology is rapidly evolving. In the past few years, we have seen the introduction and establishment of many novel surgical adjuncts, techniques, and disruptive ablative technologies that have impacted the field. Methods: We identified the most influential articles on technological developments in surgical and interventional thyroidology that were published from September 1, 2020, to August 1, 2021. We searched three electronic databases and consulted experts. Results: Major findings are summarized. Continuous intraoperative nerve monitoring (cIONM) lowered the risk of early postoperative vocal cord palsy 1.8-fold and permanent palsy 29 · 4-fold compared with intermittent intraoperative nerve monitoring. Parathyroid autofluorescence yielded a diagnostic odds ratio (OR) of 228.9 for detection of parathyroid glands over visualization, with 96% sensitivity and 92% specificity. There was no significant difference in the incidence of major complications between the transoral endoscopic thyroidectomy vestibular approach (TOETVA) and transcervical thyroidectomy (1.5% vs. 2.1%, p = 0.75), and a higher body mass index did not lead to a significant increase in the odds of cumulative complication with TOETVA for the overweight (OR = 0.52 [95% confidence interval {CI} 0.17-1.58]) and obese groups (OR = 1.69 [CI 0.74-3.88]). Radiofrequency ablation (RFA) for benign thyroid nodules typically resulted in a 50-85% volume reduction with faster recovery times, less pain levels, and higher social and psychological well-being compared with conventional thyroidectomy at 15 months post-treatment, although physical well-being levels were higher in the conventional thyroidectomy group at this time. RFA for papillary thyroid microcarcinoma showed no significant difference in local tumor progression (1.8% vs. 3.3%, p = 0.209), lymph node metastasis (0.6% vs. 0.6%, p = 1.000), recurrence (1.2% vs. 2.4%, p = 0.244), and 4-year recurrence-free survival rates (98.2% vs. 97.0%, p = 0.223) when compared with transcervical lobectomy. Conclusions: cIONM, parathyroid autofluorescence, transoral vestibular approach thyroid surgery, and RFA for benign and malignant thyroid nodules are some of the latest additions to the surgeon's and interventionalist's armamentarium to manage thyroid disease. These technological advancements demonstrate promise to improve outcomes, decrease complications, and enhance a patient's quality of life, but further rigorous studies are needed to define their utility and value.
Asunto(s)
Procedimientos Quirúrgicos Endocrinos/tendencias , Calidad de Vida/psicología , Procedimientos Quirúrgicos Endocrinos/métodos , Humanos , Glándulas Paratiroides/cirugía , Ablación por Radiofrecuencia/métodos , Glándula Tiroides/cirugía , Tiroidectomía/métodos , Parálisis de los Pliegues Vocales/cirugíaRESUMEN
BACKGROUND: The aim of this study was to determine trends in the experience of general surgery residents with endocrine surgery cases. METHODS: American Association of Endocrine Surgeons national general surgery case logs from 1989 through 2019 were reviewed. The numbers of individuals completing residency and the mean and median number of endocrine surgery cases by type and by level of operating resident surgeon were abstracted from annual data and analyzed. Descriptive statistics and linear regression analyses were performed modeling endocrine surgery cases over time and stratified by procedure type and resident level. RESULTS: The number of individuals completing general surgery residency each year increased from 981 to 1,219 (P < .001). The average total number of endocrine surgery cases performed increased from 17 to 33.2 (P < .001) but has declined since its peak at 36.9 in 2010 to 2011 (P = .014). Thyroid operations increased from 11.4 to 19.8 (P < .001) but peaked at 23.5 in 2010 to 2011 and have since declined (P < .001). Parathyroid operations more than doubled from 4.2 to 9.7 (P < .001). Adrenal operations increased from 1 to 2.2 (P < .001) and pancreatic endocrine operations increased from 0.2 to 1.5 (P < .001). Surgeon Chief endocrine surgery cases peaked at 14.4 in 2003 to 2004 but have since declined by 22.2% (P < .001). Surgeon Junior endocrine surgery cases increased overall (P < .001) but peaked at 22.8 in 2011 to 2012. There was increasing heterogeneity over time in trainee experience (P < .001). CONCLUSION: After having increased for 2 decades, the number of endocrine surgery cases performed by general surgery residents is currently in decline. Possible contributing factors include growth in the number of general surgery residents, variable and narrowed case mix, and encroachment by other learners.
Asunto(s)
Procedimientos Quirúrgicos Endocrinos/educación , Procedimientos Quirúrgicos Endocrinos/tendencias , Cirugía General/educación , Internado y Residencia/tendencias , Competencia Clínica , Procedimientos Quirúrgicos Endocrinos/estadística & datos numéricos , Humanos , Estudios Longitudinales , Estados UnidosRESUMEN
El uso de la fluorescencia en cirugía se ha ampliado y difundido en los últimos años, lo que ha constituido un auténtico fenómeno tecnológico ligado a la aparición de dispositivos adaptados a su utilización en los abordajes laparoscópicos y robóticos. La cirugía guiada por fluorescencia en el campo de la cirugía endocrina está igualmente en auge. Cada vez son más los artículos que describen su uso en la cirugía de las glándulas tiroides, paratiroides y suprarrenal, aunque con series aun modestas y con protocolos diversos no estandarizados. Existen actualmente diversas áreas de desarrollo de la aplicación de la fluorescencia en cirugía endocrina. Cabe destacar el uso de la fluorescencia con verde de indocianina en cirugía suprarrenal, la identificación y predicción de la perfusión paratiroidea con verde de indocianina, y la autofluorescencia de las glándulas paratiroides. El objetivo de este artículo es revisar las actuales aplicaciones de la fluorescencia en cirugía endocrina
The use of fluorescence in surgery has expanded and become widespread in recent years, which has led to a real technological phenomenon with the emergence of devices adapted for use in laparoscopic and robotic approaches. Fluorescence-guided surgery in the field of endocrine surgery is also on the rise. More and more articles describe its use in surgery of the thyroid, parathyroid and adrenal glands, although the series are still modest in size and protocols have not been standardized. There are currently several developing areas for the application of fluorescence in endocrine surgery, including the use of fluorescence with indocyanine green in adrenal gland surgery, the identification and prediction of parathyroid perfusion with indocyanine green, and autofluorescence of the parathyroid glands. The objective of this article is to review the current applications of fluorescence in endocrine surgery
Asunto(s)
Humanos , Procedimientos Quirúrgicos Endocrinos/tendencias , Fluorescencia , Cirugía Asistida por Computador/tendencias , Glándula Tiroides/cirugía , Glándulas Paratiroides/cirugía , Glándulas Suprarrenales/cirugía , Verde de Indocianina , Vena Cava Inferior/diagnóstico por imagen , Glándulas Paratiroides/diagnóstico por imagen , Trazadores RadiactivosRESUMEN
Although several thyroid associations have published various guidelines, controversies especially in cases of micropapillary thyroid cancer (MPTC) still exist. This survey was designed to collect information about diagnostic tests and treatments performed on patients with MPTC and help identify current trends in thyroid surgery.We developed questionnaires about the management methods for MPTC, which were used to identify factors related to indications of fine needle aspiration (FNA), type of surgery, and central lymph node dissection (CLND). Active 60 members of the Korean Society of Thyroid-Head and Neck Surgery participated in the study in September 2016.Ultrasound-guided FNA was usually initiated when the tumor was at least 5âmm (60%). All respondents preferred ultrasound-guided FNA and surgery for nodules with extrathyroidal extension (ETE). The preferred treatment option for intraglandular MPTC was lobectomy (92%) rather than active surveillance (8%). Posterolateral ETE increased the respondents' preference for total thyroidectomy (61.7%). Active surveillance was preferred for tumors <5âmm, which was decreased by the presence of ETE. The presence of ETE (73.3%) and its proximity to critical organs (46.7%) were the main determining factors for prophylactic CLND. For multiple metastatic lymph nodes at level III, selective neck dissection including levels IIb (23.3%) and V (78.3%) was preferred in addition to levels IIa, III, VI, and V.Korean head and neck surgeons favored total thyroidectomy and CLND in cases wherein ETE, central lymph node metastasis, or critical organ involvement was suspected.
Asunto(s)
Procedimientos Quirúrgicos Endocrinos/tendencias , Neoplasias de la Tiroides/diagnóstico , Neoplasias de la Tiroides/cirugía , Adulto , Humanos , Corea (Geográfico) , Persona de Mediana Edad , Sociedades Médicas , Cirujanos , Encuestas y Cuestionarios , Ultrasonografía Intervencional/tendenciasRESUMEN
OBJECTIVE: Acromegaly is a rare disease characterized by hypersecretion of growth hormone (GH), typically from a benign pituitary somatotroph adenoma, that leads to subsequent hypersecretion of insulin-like growth factor 1 (IGF-1). Patients with acromegaly have an increased risk of mortality and progressive worsening of comorbidities. Surgery, medical therapy, and radiotherapy are currently available treatment approaches for patients with acromegaly, with overall therapeutic goals of lowering GH levels and achieving normal IGF-1 levels, reducing tumor size, improving comorbidities, and minimizing mortality risk. Although surgery can lead to biochemical remission in some patients with acromegaly, many patients will continue to have uncontrolled disease and require additional treatment. METHODS: We reviewed recently published reports and present a summary of the safety and efficacy of current treatment modalities for patients with acromegaly. RESULTS: A substantial proportion of patients who receive medical therapy or radiotherapy will have persistently elevated GH and/or IGF-1. Because of the serious health consequences of continued elevation of GH and IGF-1, there is a need to improve therapeutic approaches to optimize biochemical control, particularly in high-need patient populations for whom current treatment options provide limited benefit. CONCLUSION: This review discusses current treatment options for patients with acromegaly, limitations associated with each treatment approach, and areas within the current treatment algorithm, as well as patient populations for which improved therapeutic options are needed. Novel agents in development were also highlighted, which have the potential to improve management of patients with uncontrolled or persistent acromegaly.
Asunto(s)
Acromegalia/terapia , Adenoma/terapia , Adenoma Hipofisario Secretor de Hormona del Crecimiento/terapia , Acromegalia/diagnóstico , Acromegalia/etiología , Adenoma/complicaciones , Adenoma/diagnóstico , Diagnóstico Diferencial , Agonistas de Dopamina/uso terapéutico , Quimioterapia Combinada , Procedimientos Quirúrgicos Endocrinos/métodos , Procedimientos Quirúrgicos Endocrinos/tendencias , Adenoma Hipofisario Secretor de Hormona del Crecimiento/complicaciones , Adenoma Hipofisario Secretor de Hormona del Crecimiento/diagnóstico , Humanos , Planificación de Atención al Paciente , Somatostatina/uso terapéuticoRESUMEN
Over the last two decades, surgery for primary hyperparathyroidism has evolved to offer a panel of procedures based on improvements in imaging, new technology and, consequently, novel surgical techniques. Multiple courses of action are possible, consistent with varying degrees of complexity. From the simplest scenario of a single adenoma localized by at least two preoperative tests in the context of sporadic primary hyperparathyroidism, to revision surgery related to recurrent, persistent or multiglandular disease, the surgeon has the opportunity to adapt his strategy. However, whatever surgical approach is used, even in the absence of formal guidelines, the clinical judgment of an experienced and skilled practitioner in endocrine surgery is the real guide and key of success in complex situations.
Asunto(s)
Hiperparatiroidismo Primario/cirugía , Adenoma/cirugía , Diagnóstico por Imagen , Procedimientos Quirúrgicos Endocrinos/métodos , Procedimientos Quirúrgicos Endocrinos/tendencias , Humanos , Hiperparatiroidismo Primario/patología , Neoplasias de las Paratiroides/cirugía , Paratiroidectomía/métodosRESUMEN
BACKGROUND: Endocrine surgery is a specialty that is evolving constantly. In this study, we sought to delineate the practice patterns of surgeons taking care of endocrine diseases in present-day academic centers. METHODS: A review of the Faculty Practice Solutions Center database was conducted for the years 2005, 2009, and 2013. Practice patterns were determined by International Classification of Diseases, 9th Revision and Current Procedural Terminology codes, and analyzed for practice composition, regional variability, and volume of endocrine operations. RESULTS: Of 97 national academic centers, 52 were identified to have 120 practicing American Association of Endocrine Surgeons (AAES) surgeons in the study. On average, endocrine operations comprise â¼65% of the AAES surgeon's practice, and 51% are considered high-volume surgeons for thyroidectomy, parathyroidectomy, and adrenalectomy. Most non-AAES surgeons who perform endocrine operations are otolaryngologists (24.5%) and other general surgeons (18.5%). Overall, non-AAES surgeons perform the majority of endocrine operations at academic institutions (61.6%), and low-volume surgeons perform most of these operations (55.6%). CONCLUSION: Research has shown that high-volume surgeons have improved outcomes. Even in academia, however, the majority of endocrine operations are performed by low-volume surgeons, suggesting that there is an opportunity for expanding the number of surgeons with expertise in endocrine surgery in present-day academic centers.
Asunto(s)
Centros Médicos Académicos , Procedimientos Quirúrgicos Endocrinos/normas , Enfermedades del Sistema Endocrino/cirugía , Pautas de la Práctica en Medicina/tendencias , Adrenalectomía/normas , Adrenalectomía/tendencias , Bases de Datos Factuales , Procedimientos Quirúrgicos Endocrinos/tendencias , Enfermedades del Sistema Endocrino/diagnóstico , Femenino , Investigación sobre Servicios de Salud , Humanos , Masculino , Evaluación de Necesidades , Paratiroidectomía/normas , Paratiroidectomía/tendencias , Competencia Profesional , Mejoramiento de la Calidad , Tiroidectomía/normas , Tiroidectomía/tendencias , Estados Unidos , Recursos HumanosAsunto(s)
Técnicas de Diagnóstico Endocrino/normas , Procedimientos Quirúrgicos Endocrinos/normas , Bocio Nodular/diagnóstico , Bocio Nodular/terapia , Mejoramiento de la Calidad , Biopsia con Aguja Fina/normas , Diagnóstico por Imagen/métodos , Diagnóstico por Imagen/tendencias , Técnicas de Diagnóstico Endocrino/tendencias , Procedimientos Quirúrgicos Endocrinos/tendencias , Bocio Nodular/epidemiología , Bocio Nodular/patología , Historia del Siglo XX , Historia del Siglo XXI , HumanosRESUMEN
Transsphenoidal surgery is the treatment of choice for acromegaly due to pituitary adenoma but it is not always possible to reduce or control tumor growth, inhibit GH hypersecretion and normalize IGF-I. The first-line drug treatment in 2013 remains the somatostatin analogues. In 2012 and 2013 have been published several publications presenting the prognosis of well-differentiated thyroid cancers of intermediate risk. Indeed, the dose of radioactive iodine administered to patients with "favorable" histology in this risk category should be reduced without change in prognosis. Elastograhy could, in combination with conventional ultrasound features, allow a better selection of thyroid nodules that need a cytology, with, however, still limitations in the detection of follicular carcinomas.
Asunto(s)
Endocrinología/tendencias , Acromegalia/cirugía , Adenocarcinoma Folicular/diagnóstico , Adenoma/cirugía , Diagnóstico por Imagen de Elasticidad/tendencias , Procedimientos Quirúrgicos Endocrinos/métodos , Procedimientos Quirúrgicos Endocrinos/tendencias , Endocrinología/métodos , Humanos , Neoplasias Hipofisarias/cirugía , Seno Esfenoidal/cirugía , Neoplasias de la Tiroides/diagnósticoRESUMEN
This article reviews translational research in endocrine surgery, with a focus on disorders of the thyroid, parathyroids, adrenals, and endocrine pancreas. Discovery of genes responsible for heritable endocrine cancer syndromes has increased knowledge of the causes and mechanisms of endocrine cancer and has refined surgical treatment options. Knowledge of mutations in sporadic cancer has led to rapid progress in small-molecule kinase inhibitor strategies. These breakthroughs and their influence on current therapy are discussed to provide surgeons with an overview of the basic science research currently creating new clinical treatments and improving patient care.
Asunto(s)
Procedimientos Quirúrgicos Endocrinos/tendencias , Enfermedades del Sistema Endocrino/cirugía , Investigación Biomédica Traslacional , Animales , HumanosRESUMEN
Recent advances in the field of thyroid surgery include the release of the clinical practice guidelines for thyroid tumors, organization of multicenter collaborative research groups studying rare diseases such as multiple endocrine neoplasia (including hereditary medullary thyroid carcinoma) and anaplastic thyroid carcinoma, and development of surgical skills and devices that play a part in securing patients' safety and satisfaction. Endocrine surgeons are privileged to pose and solve many unanswered questions that are relevant to good clinical practice for patients with surgical thyroid disorders in the future.
Asunto(s)
Tiroidectomía , Procedimientos Quirúrgicos Endocrinos/tendencias , Humanos , Japón , Glándula Tiroides/cirugía , Neoplasias de la Tiroides/cirugíaRESUMEN
Technical advances and focusing on subsets modified endocrine surgery in the last ten years tremendously. There is on one side a clear trend towards minimal invasive approaches, first of all in the surgery of the adrenal glands, where the transperitoneal or retroperitoneal laparoscopic adrenalectomy has become the gold standard for tumors up to a size of 10 cm in diameter. But also in pancreatic endocrine surgery for small tumors localized in the pancreas tail and up to a certain extend in thyroid and parathyroid surgery, laparoscopic or video assisted techniques are used. On the other side more precise techniques allow a more complete and radical removal of endocrine tissue, especially in thyroid surgery. This article presents a summary of current operative techniques and strategies in endocrine surgery.
Asunto(s)
Glándulas Endocrinas/cirugía , Procedimientos Quirúrgicos Endocrinos/instrumentación , Procedimientos Quirúrgicos Endocrinos/métodos , Enfermedades del Sistema Endocrino/cirugía , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Procedimientos Quirúrgicos Mínimamente Invasivos/tendencias , Procedimientos Quirúrgicos Endocrinos/tendencias , HumanosRESUMEN
The only therapy with the potential for complete cure of patients with gastroenteropancreatic neuroendocrine tumors is complete surgical excision. Surgical options per se are often dictated by the tumor's site of origin, degree of tumor burden, and overall health or debility of the individual patient. This article considers different options based on the type of tumor and site of origin.